15-epi-18,19-Dihydroantirhine (54984-44-0)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 19-Epi FK-506
- 15-Epi-Danshenol-A
- (4α)-2β-Hydroxy-15-oxo-19-norkauran-18-oic acid
- dynorphin A (1-13), Tyr(14)-Leu(15)-Phe(16)-Asn(17)-Gly(18)-Pro(19)-
- (-)-4,4,8-Trimethyl-18-nor-15-oxa-5α-androsta-13,16-diene-19-oic acid
- 18-Beta-hydroxy-3-epi-alpha-yohimbine
- 19-Deoxy-15-chlorojanerin
- 19-Norkaur-16-en-18-oicacid, 2-[(3,4-di-O-sulfo-a-D-glucopyranosyl)oxy]-15-hydroxy-, (2b,4a,15a)- (9CI)
- 1/C15H10O4/c16-11-7-3-1-5-9(11)15-14(18)13(17)10-6-2-4-8-12(10)19-15/h1-8,16,18
- 19-Norkaur-16-en-18-oicacid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-b-D-glucopyranosyl]oxy]-,dipotassium salt, (2b,15a)- (9CI)
- 19-Norkaur-16-en-18-oicacid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-b-D-glucopyranosyl]oxy]-, disodiumsalt, (2b,4a,15a)- (9CI)
- 15α-hydroxy-2β-[[2-O-isovaleryl-3,4α-di-O-sulpho-β-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid
- 1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
- 1/C17H18OS/c1-4-11-7-5-8-12-13-9-6-10-14(17(2,3)18)16(13)19-15(11)12/h5-10,18H,4H2,1-3H
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 1-19-Atrial natriureticpeptide-21 (rat),N-L-arginyl-14-de-L-glutamine-15-de-L-serine-16-deglycine-17-de-L-leucine-18-deglycine-19-L-cysteinamide-(9CI)
- 1/C16H15FN2O3S/c1-23(21,22)19-14-5-3-2-4-13(14)18-16(20)10-15(19)11-6-8-12(17)9-7-11/h2-9,15H,10H2,1H3,(H,18,20
- 1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
- 1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
- 1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H